<DOC>
	<DOC>NCT00716404</DOC>
	<brief_summary>This is a prospective, observational, multi-center study with consecutive enrollment. Up to 1,000 patients will be enrolled. The objective of this post-marketing surveillance study is to collect clinical usage patterns of the Benephit Infusion Systems. As a result, FlowMedica will be able to: 1. Better understand and quantify usage patterns including patient characteristics, adjunctive procedures, and infusion agents. 2. Collect user-interface information and overall customer satisfaction. 3. Monitor post-marketing device performance.</brief_summary>
	<brief_title>Post-Market Observational Study of Intra-Renal Drug Delivery</brief_title>
	<detailed_description />
	<mesh_term>Renal Agents</mesh_term>
	<criteria>Exposure to one or more components of the Benephit Infusion System Ability to give written informed consent Inclusion in another clinical study that may affect usage of the Benephit system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>FlowMedica</keyword>
	<keyword>Benephit</keyword>
	<keyword>TRT</keyword>
	<keyword>Patients</keyword>
	<keyword>Components</keyword>
	<keyword>Benephit Infusion System</keyword>
	<keyword>Planned</keyword>
	<keyword>To be used</keyword>
</DOC>